The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients

The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients

4.9
(297)
Write Review
More
$ 7.00
Add to Cart
In stock
Description

A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB) - ScienceDirect

Epidermolysis Bullosa (EB) Misdiagnosis Association and Research institute

PDF) Homocysteine metabolism in children and adolescents with epidermolysis bullosa

A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). - Abstract

Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center, Italian Journal of Pediatrics

PDF) Homocysteine metabolism in children and adolescents with epidermolysis bullosa

What is EB? - EB-Research

Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa

A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). - Abstract

Epidermolysis bullosa Nature Reviews Disease Primers

A single-centre study on predictors and determinants of pubertal delay and growth impairment in Epidermolysis Bullosa

Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) Clement C.H. Loh, BSc Med (Hons. - ppt download

Pediatric Epidermolysis Bullosa: Practice Essentials, Background, Pathophysiology